TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $65,000 | -69.8% | 65,000 | -45.6% | 0.00% | – |
| Q3 2022 | $215,000 | -6.5% | 119,500 | +51.1% | 0.00% | – |
| Q2 2022 | $230,000 | -71.9% | 79,100 | -55.0% | 0.00% | – |
| Q4 2021 | $818,000 | -42.5% | 175,602 | +5.0% | 0.00% | – |
| Q3 2021 | $1,423,000 | -42.0% | 167,246 | +11.9% | 0.00% | – |
| Q2 2021 | $2,453,000 | +14.8% | 149,469 | +54.4% | 0.00% | – |
| Q1 2021 | $2,137,000 | -78.9% | 96,782 | -70.4% | 0.00% | – |
| Q4 2020 | $10,122,000 | +478.4% | 327,264 | +280.1% | 0.00% | – |
| Q3 2020 | $1,750,000 | +185.0% | 86,099 | +115.6% | 0.00% | – |
| Q2 2020 | $614,000 | +127.4% | 39,942 | +14.6% | 0.00% | – |
| Q1 2020 | $270,000 | – | 34,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |